These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3008020)

  • 21. Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome.
    Facchinetti F; Fioroni L; Martignoni E; Sances G; Costa A; Genazzani AR
    Psychosom Med; 1994; 56(5):418-22. PubMed ID: 7809341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulatory effect of naloxone on plasma cortisol in human: Possible direct stimulatory action at the adrenal cortex.
    Coiro V; Volpi R; Stella A; Venturi N; Chiodera P
    Regul Pept; 2011 Jan; 166(1-3):1-2. PubMed ID: 20728478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.
    Schluger JH; Ho A; Borg L; Porter M; Maniar S; Gunduz M; Perret G; King A; Kreek MJ
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1430-6. PubMed ID: 9802524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different effects of aging on the opioid mechanisms controlling gonadotropin and cortisol secretion in man.
    Coiro V; Passeri M; Volpi R; Marchesi M; Bertoni P; Fagnoni F; Schianchi L; Bianconi L; Marcato A; Chiodera P
    Horm Res; 1989; 32(4):119-23. PubMed ID: 2560454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexpected inhibitory action of N-methyl-D,L-aspartate or luteinizing hormone release in adult ovariectomized rhesus monkeys: a role of the hypothalamic-adrenal axis.
    Reyes A; Luckhaus J; Ferin M
    Endocrinology; 1990 Aug; 127(2):724-9. PubMed ID: 2197080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
    Buyalos RP; Jackson RV; Grice GI; Hockings GI; Torpy DJ; Fox LM; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine regulation of sheep fetuses.
    Brooks AN; Currie IS; Gibson F; Thomas GB
    J Reprod Fertil Suppl; 1992; 45():69-84. PubMed ID: 1338958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of a role of the hypothalamic-pituitary-adrenal axis in the fasting-induced suppression of luteinizing hormone secretion in adult male rhesus monkeys (Macaca mulatta).
    Helmreich DL; Mattern LG; Cameron JL
    Endocrinology; 1993 Jun; 132(6):2427-37. PubMed ID: 8389280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid modulation of the hypothalamo-pituitary-adrenal axis in dairy cows.
    Nanda AS; Dobson H; Ward WR
    Domest Anim Endocrinol; 1992 Jul; 9(3):181-6. PubMed ID: 1458871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
    Dökmetaş HS; Colak R; Keleştimur F; Selçuklu A; Unlühizarci K; Bayram F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal variations in endocrine and psychological responses to 0.2 mg/kg naloxone administration in patients with major depressive disorder and matched controls.
    Martín del Campo AF; Dowson JH; Herbert J; Paykel ES
    J Affect Disord; 2000; 57(1-3):37-47. PubMed ID: 10708814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of naloxone on endogenous opioid regulation of pituitary gonadotropins and prolactin during the menstrual cycle.
    Snowden EU; Khan-Dawood FS; Dawood MY
    J Clin Endocrinol Metab; 1984 Aug; 59(2):298-302. PubMed ID: 6330154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
    Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
    Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism.
    Fallo F; Boscaro M; Sonino N; Mantero F
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):163-8. PubMed ID: 2822294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of endotoxin on LH secretion in the ovariectomized monkey are prevented by naloxone but not by an interleukin-1 receptor antagonist.
    Xiao E; Xia-Zhang L; Ferin M
    Neuroimmunomodulation; 2000; 7(1):6-15. PubMed ID: 10601814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids.
    Gudbjörnsson B; Skogseid B; Oberg K; Wide L; Hällgren R
    J Rheumatol; 1996 Apr; 23(4):596-602. PubMed ID: 8730111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.